Dynamic influence of pentoxifylline on the oxygen status of Pliss’s lymph sarcoma in rat

Tatiana I. KALGANOVA, Anna G. ORLOVA, German Yu. GOLUBYATNIKOV, Anna V. MASLENNIKOVA, Ilya V. TURCHIN

PDF(294 KB)
PDF(294 KB)
Front. Optoelectron. ›› 2017, Vol. 10 ›› Issue (3) : 317-322. DOI: 10.1007/s12200-017-0725-5
RESEARCH ARTICLE
RESEARCH ARTICLE

Dynamic influence of pentoxifylline on the oxygen status of Pliss’s lymph sarcoma in rat

Author information +
History +

Abstract

Tumor oxygenation is one of the key factors influencing disease prognosis and the effectiveness of treatment. Assessment of tumor oxygenation levels facilitates the selection of optimum conditions for radiation therapy, and plays an important role in creating alternative regimes of irradiation. Treating tumors with agents capable of increasing tumor oxygenation in order to increase radiosensitivity is a promising avenue of enquiry. Diffuse optical spectroscopy (DOS) allows a noninvasive determination of tissue oxygen levels based on information about the local changes in optical parameters, and the visualization of metabolic processes in the region of interest. DOS allows reconstruction of the two-dimensional distribution of main tissue chromophores that characterize the processes of oxygen supply (oxygenated hemoglobin) and oxygen consumption (deoxygenated hemoglobin), as well as the blood oxygen saturation levels, which indirectly reflect the tissue oxygenation levels. In the present study, a hemorheologic drug, pentoxifylline, which can improve microcirculation in regions with circulatory disturbances, was used for modifying tumor tissue oxygenation. Pliss’s lymph sarcoma (PLS), which is characterized by rapid growth and early occurrence of necrotic areas, was chosen as a tumor model. Tumor oxygenation was monitored by DOS with parallel plane geometry. Pentoxifylline could improve tumor oxygenation by increasing the concentration of oxyhemoglobin. The increased blood oxygen saturation persisted from 30 to 120 min after drug administration. Normal healthy tissue (muscle) and tumor tissue responded differently to the drug. DOS can be used for testing new agents that influence tissue oxygen status and blood-filling rate.

Keywords

tumor oxygenation / diffuse optical spectroscopy (DOS) / pentoxifylline / Pliss’s lymph sarcoma (PLS)

Cite this article

Download citation ▾
Tatiana I. KALGANOVA, Anna G. ORLOVA, German Yu. GOLUBYATNIKOV, Anna V. MASLENNIKOVA, Ilya V. TURCHIN. Dynamic influence of pentoxifylline on the oxygen status of Pliss’s lymph sarcoma in rat. Front. Optoelectron., 2017, 10(3): 317‒322 https://doi.org/10.1007/s12200-017-0725-5

References

[1]
Busk M, Horsman M R. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine (AIMN) and the International Association of Radiopharmacology (IAR), and Section of the Society of Radiopharmaceutical Sciences, 2013, 57(3): 219–234
[2]
JoinerM C, van der KogelA. Basic Clinical Radiobiology.4th ed. Abingdon, Oxon: CRC Press, 2009
[3]
Howard-Flanders P, Moore D. The time interval after pulsed irradiation within which injury to bacteria can be modified by dissolved oxygen I. A search for an effect of oxygen 0.02 second after pulsed irradiation. Radiation Research, 1958, 9(4): 422–437
CrossRef Pubmed Google scholar
[4]
Michael B D, Adams G E, Hewitt H B, Jones W B, Watts M E. A posteffect of oxygen in irradiated bacteria: a submillisecond fast mixing study. Radiation Research, 1973, 54(2): 239–251
CrossRef Pubmed Google scholar
[5]
www.webvidal.ru
[6]
Bennewith K L, Durand R E. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity. British Journal of Cancer, 2001, 85(10): 1577–1584
CrossRef Pubmed Google scholar
[7]
Honess D J, Andrews M S, Ward R, Bleehen N M. Pentoxifylline increases Rif-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion. Acta Oncologica (Stockholm, Sweden), 1995, 34(3): 385–389160;
CrossRef Pubmed Google scholar
[8]
Kaanders J H, Bussink J, van der Kogel A J. ARCON: a novel biology-based approach in radiotherapy. The Lancet Oncology, 2002, 3(12): 728–737
CrossRef Pubmed Google scholar
[9]
Pliss G B. Oncological specification of a new strain of rat lymphosarcoma. Bulletin of Experimental Biology and Medicine, 1961, 2: 95–99. 
[10]
Orlova A G, Turchin I V, Plehanov V I, Shakhova N M, Fiks I I, Kleshnin M I, Konuchenko N Yu, Kamensky V A. Frequency-domain diffuse optical tomography with single source-detector pair for breast cancer detection. Laser Physics Letters, 2008, 5(4): 321–327
CrossRef Google scholar
[11]
Maslennikova A V, Orlova A G, Golubiatnikov G Yu, Kamensky V A, Shakhova N M, Babaev A A, Snopova L B, Ivanova I P, Plekhanov V I, Prianikova T I, Turchin I V. Comparative study of tumor hypoxia by diffuse optical spectroscopy and immunohistochemistry in two tumor models. Journal of Biophotonics, 2010, 3(12): 743–751
CrossRef Pubmed Google scholar
[12]
De Blasi R A, Cope M, Elwell C, Safoue F, Ferrari M. Noninvasive measurement of human forearm oxygen consumption by near infrared spectroscopy. European Journal of Applied Physiology and Occupational Physiology, 1993, 67(1): 20–25
CrossRef Pubmed Google scholar
[13]
Lu H, Golay X, Pekar J J, Van Zijl P C M. Sustained poststimulus elevation in cerebral oxygen utilization after vascular recovery. Journal of Cerebral Blood Flow and Metabolism, 2004, 24(7): 764–770
CrossRef Pubmed Google scholar
[14]
Zywietz F, Böhm L, Sagowski C, Kehrl W. Pentoxifyllin stimuliert die Tumoroxygenierung und Strahlensensibilität von Rhabdomyosarkomen der Ratte während kontinuierlicher hyperfraktionierter Bestrahlung. Strahlentherapie und Onkologie, 2004, 180(5): 306–314
CrossRef Pubmed Google scholar
[15]
McCarty M F, O’Keefe J H, DiNicolantonio J J. Pentoxifylline for vascular health: a brief review of the literature. Open Heart, 2016, 3(1): e000365
CrossRef Pubmed Google scholar
[16]
Brown J M, Giaccia A J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research, 1998, 58(7): 1408–1416
Pubmed
[17]
Hida K, Maishi N, Torii C, Hida Y. Tumor angiogenesis--characteristics of tumor endothelial cells. International Journal of Clinical Oncology, 2016, 21(2): 206–212
CrossRef Pubmed Google scholar
[18]
Price M J, Li L T, Tward J D, Bublik I, McBride W H, Lavey R S. Effect of nicotinamide and pentoxifylline on normal tissue and FSA tumor oxygenation. Acta Oncologica (Stockholm, Sweden), 1995, 34(3): 391–395
CrossRef Pubmed Google scholar
[19]
Moulder J E, Robbins M E C, Cohen E P, Hopewell J W, William F. Ward W F. Pharmacologic modification of radiation-induced late normal tissue injury. In: Mittal B B, Purdy J A, Ang K K, eds. Advances in Radiation Therapy. Berlin: Springer Science & Business Media, 2012, 129–151

Acknowledgements

the authors extend their gratitude to I. P. Ivanova for creation of tumor models, to V. I. Plekhanov, V. A. Vorobyov for technical support of the studies, to A. S. Plekhanova, A. B. Volovetsky for assistance during the experiments. This work was supported by Russian Foundation for Basic Research (project No. 15-42-02528) for in vivo DOS experiments and statistical analysis. The study is supported by the Governmental project of the Institute of Applied Physics RAS (project No 0035-2014-0008) for DOS data reconstruction. The authors declare no conflict of interests.

RIGHTS & PERMISSIONS

2017 Higher Education Press and Springer-Verlag Berlin Heidelberg
AI Summary AI Mindmap
PDF(294 KB)

Accesses

Citations

Detail

Sections
Recommended

/